|
Index of reports
> Cases resulting in other serious reactions (56)
> Cases with Drug Exposure During Pregnancy (8)
Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in other serious reactions where reactions include drug exposure during pregnancy.
Adverse event in 28 year old female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient: 28 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Morphine
Administration route: Oral
Retrovir
Administration route: Oral
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: HIV Infection
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-17
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Stillbirth, Foetal Malformation
Adverse event resulted in: death
Suspect drug(s):
Retrovir
Dosage: 500mg per day
Indication: HIV Infection
Videx
Dosage: 250mg per day
Indication: HIV Infection
Viramune
Indication: HIV Infection
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03
Patient:
Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly
Suspect drug(s):
Epivir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Quinine Sulfate
Dosage: transplacentary
Indication: Plasmodium Falciparum Infection
Retrovir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03
Patient:
Adverse reactions / side effects: Caesarean Section, Lymphadenopathy, Drug Exposure During Pregnancy, HIV Infection, Human Immunodeficiency Virus Transmission, Failure TO Thrive, Hepatosplenomegaly
Suspect drug(s):
Didanosine
Indication: Antiviral Prophylaxis
Didanosine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: single dose
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Retrovir
Indication: Antiviral Prophylaxis
Retrovir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a physician from United States on 2007-02-08
Patient: male
Adverse reactions / side effects: Nose Deformity, Drug Exposure During Pregnancy, Premature Baby, Congenital Anomaly, Talipes
Adverse event resulted in: disablity
Suspect drug(s):
Efavirenz
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Retrovir
Start date: 2005-12-29
Viramune
Start date: 2005-12-29
Other drugs received by patient: Epivir; Zerit; Bactrim; Vitamin B Complex CAP
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-12
Patient: male
Adverse reactions / side effects: Platelet Count Increased, Skull Malformation, Anaemia Macrocytic, Laboratory Test Abnormal, Drug Exposure During Pregnancy, Vision Blurred, Neutropenia, Talipes
Suspect drug(s):
Combivir
Indication: HIV Infection
Retrovir
Indication: HIV Infection
Start date: 2002-07-11
End date: 2002-07-11
Retrovir
Viracept
Indication: HIV Infection
Other drugs received by patient: Bactrim
Adverse event in 19 year old female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-08
Patient: 19 year old female
Adverse reactions / side effects: Premature Baby, Drug Exposure During Pregnancy, Anaemia
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-06-05
Retrovir
Dosage: 1mgkh per day
Indication: HIV Infection
Start date: 2006-10-24
End date: 2006-10-24
Zidovudine
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-06-05
Other drugs received by patient: Kaletra; Viracept; Trimethoprim + Sulfamethoxazole; Macrobid; Clotrimazole Troches; Reglan; Promethazine; Cefazolin
|
